- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of Human Papillomavirus Vaccines: A Review
Authors
Keywords
Complex Regional Pain Syndrome, Injection Site Reaction, Vaccine Recipient, Vaccine Adverse Event Reporting System, Injection Site Pain
Journal
DRUG SAFETY
Volume 36, Issue 6, Pages 393-412
Publisher
Springer Nature
Online
2013-05-01
DOI
10.1007/s40264-013-0039-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
- (2013) Payam Nahid et al. BMC INFECTIOUS DISEASES
- Losartan vs Candesartan for Heart Failure—Reply
- (2013) Henrik Svanström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anaphylaxis as an adverse event following immunisation in the UK and Ireland
- (2012) Michel Erlewyn-Lajeunesse et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Complex regional pain syndrome following immunisation
- (2012) Stephanie Richards et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to Females
- (2012) Nicola P. Klein et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Telogen Effluvium following Bivalent Human Papillomavirus Vaccine Administration: A Report of Two Cases
- (2012) Marco Tuccori et al. DERMATOLOGY
- Four-Year Follow-up of the Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine When Administered to Adolescent Girls Aged 10–14 Years
- (2012) Tino F. Schwarz et al. JOURNAL OF ADOLESCENT HEALTH
- Reported Adverse Events in Young Women Following Quadrivalent Human Papillomavirus Vaccination
- (2012) Allison L. Naleway et al. JOURNAL OF WOMENS HEALTH
- Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study
- (2012) Melina Georgousakis et al. LANCET INFECTIOUS DISEASES
- Systemic lupus erythematosus following HPV immunization or infection?
- (2012) HF Soldevilla et al. LUPUS
- The Risk of Immune Thrombocytopenic Purpura After Vaccination in Children and Adolescents
- (2012) S. T. O'Leary et al. PEDIATRICS
- Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination
- (2012) Priscilla Velentgas et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture–recapture analysis
- (2012) Wan-Ting Huang et al. VACCINE
- A Catastrophic Failure
- (2011) Edgard Wehbe AMERICAN JOURNAL OF MEDICINE
- Safety of the HPV Bivalent and Quadrivalent Vaccines during Pregnancy
- (2011) Alicia B Forinash et al. ANNALS OF PHARMACOTHERAPY
- End-of-study safety, immunogenicity and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
- (2011) X Castellsagué et al. BRITISH JOURNAL OF CANCER
- Reported paediatric adverse drug reactions in the UK 2000-2009
- (2011) Daniel B. Hawcutt et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Papillomavirus virus like particle-based therapeutic vaccine against human papillomavirus infection related diseases: Immunological problems and future directions
- (2011) Jiezhong Chen et al. CELLULAR IMMUNOLOGY
- Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years
- (2011) Tino F. Schwarz et al. Human vaccines & immunotherapeutics
- Safety and tolerability of bivalent HPV vaccine: An Italian post-licensure study
- (2011) Roberto Gasparini et al. Human vaccines & immunotherapeutics
- Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults
- (2011) Edson D. Moreira et al. Human vaccines & immunotherapeutics
- Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule
- (2011) Barbara Romanowski et al. Human vaccines & immunotherapeutics
- Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine
- (2011) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Immunogenicity and Reactogenicity of Alternative Schedules of HPV Vaccine in Vietnam
- (2011) Kathleen M. Neuzil JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Immunogenicity Profile of Human Papillomavirus-16/18 AS04 Adjuvant Cervical Cancer Vaccine: A Randomized Controlled Trial in Healthy Adolescent Girls of Bangladesh
- (2011) S. Khatun et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial: Immunogenicity and Safety of Coadministered Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine and Combined Hepatitis A and B Vaccine in Girls
- (2011) Court Pedersen et al. JOURNAL OF ADOLESCENT HEALTH
- Human papillomavirus 16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in 15-25 years old healthy Korean women
- (2011) Seung Cheol Kim et al. Journal of Gynecologic Oncology
- Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine
- (2011) C. Chao et al. JOURNAL OF INTERNAL MEDICINE
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
- (2011) Anna R. Giuliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-adjuvanted Vaccine Coadministered With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine and/or Meningococcal Conjugate Vaccine to Healthy Girls 11 to 18 Years of Age
- (2011) Cosette M. Wheeler et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine Administered According to an Alternative Dosing Schedule Compared With the Standard Dosing Schedule in Healthy Women Aged 15 to 25 Years
- (2011) Susanna Esposito et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Active Surveillance for Adverse Events: The Experience of the Vaccine Safety Datalink Project
- (2011) W. K. Yih et al. PEDIATRICS
- Understanding the Role of Human Variation in Vaccine Adverse Events: The Clinical Immunization Safety Assessment Network
- (2011) P. S. LaRussa et al. PEDIATRICS
- Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: Randomized study in healthy girls
- (2011) Channa E. Schmeink et al. VACCINE
- Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands
- (2011) T.M. van’t Klooster et al. VACCINE
- Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
- (2011) Julianne Gee et al. VACCINE
- Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine in healthy Chinese females aged 15 to 45 years: a phase I trial
- (2011) Feng-Cai Zhu et al. Chinese Journal of Cancer
- Postural tachycardia syndrome after vaccination with Gardasil
- (2010) S. Blitshteyn EUROPEAN JOURNAL OF NEUROLOGY
- “I just signed”: Factors influencing decision-making for school-based HPV vaccination of adolescent girls.
- (2010) Spring Chenoa Cooper Robbins et al. HEALTH PSYCHOLOGY
- Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: A pooled analysis of 11 clinical trials
- (2010) Dominique Descamps et al. Human vaccines & immunotherapeutics
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women
- (2010) Tiina Petäjä et al. INTERNATIONAL JOURNAL OF CANCER
- Immunogenicity, Reactogenicity, and Safety of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women
- (2010) Ryo Konno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls
- (2010) Doris M. Rivera Medina et al. JOURNAL OF ADOLESCENT HEALTH
- Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Cervical Cancer Vaccine Coadministered With Combined Diphtheria-Tetanus-Acellular Pertussis–inactivated Poliovirus Vaccine to Girls and Young Women
- (2010) José Garcia-Sicilia et al. JOURNAL OF ADOLESCENT HEALTH
- Beyond Cervical Cancer: Burden of Other HPV-Related Cancers Among Men and Women
- (2010) Anil K. Chaturvedi JOURNAL OF ADOLESCENT HEALTH
- A 16-Year-Old Girl With Bilateral Visual Loss and Left Hemiparesis Following an Immunization Against Human Papilloma Virus
- (2010) Francis J. DiMario et al. JOURNAL OF CHILD NEUROLOGY
- Vaccination with a Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Cervical Cancer Vaccine in Korean Girls Aged 10-14 Years
- (2010) Young-Jae Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Demyelinating disease and polyvalent human papilloma virus vaccination
- (2010) J. Chang et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The India HPV-vaccine suspension
- (2010) Heidi J Larson et al. LANCET
- Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine
- (2010) Stan L. Block et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Sustained Efficacy of the Pentavalent Rotavirus Vaccine, RV5, up to 3.1 Years Following the Last Dose of Vaccine
- (2010) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance
- (2010) Michael S. Gold et al. Sexual Health
- Post-licensure monitoring of HPV vaccine in the United States
- (2010) Lauri E. Markowitz et al. VACCINE
- Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines
- (2010) A. Arguedas et al. VACCINE
- A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD®
- (2010) Paolo Bonanni et al. VACCINE
- Guillain–Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006–2009
- (2010) Nizar Souayah et al. VACCINE
- Impact of a Quadrivalent HPV6/11/16/18 Vaccine in Mexican Women: Public Health Implications for the Region
- (2009) Eduardo Lazcano-Ponce et al. ARCHIVES OF MEDICAL RESEARCH
- Ampiginous choroiditis following quadrivalent human papilloma virus vaccine
- (2009) Y M Khalifa et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Currently approved prophylactic HPV vaccines
- (2009) Diane M Harper Expert Review of Vaccines
- Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine
- (2009) Barbara A. Slade JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years
- (2009) Cosette M. Wheeler et al. JOURNAL OF INFECTIOUS DISEASES
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial
- (2009) Nubia Muñoz et al. LANCET
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- ACUTE DISSEMINATED ENCEPHALOMYELITIS FOLLOWING VACCINATION AGAINST HUMAN PAPILLOMA VIRUS
- (2009) B. Wildemann et al. NEUROLOGY
- Pregnancy Outcomes From the Pregnancy Registry of a Human Papillomavirus Type6/11/16/18 Vaccine
- (2009) Adrian Dana et al. OBSTETRICS AND GYNECOLOGY
- Pregnancy and Infant Outcomes in the Clinical Trials of a Human Papillomavirus Type 6/11/16/18 Vaccine
- (2009) Suzanne M. Garland et al. OBSTETRICS AND GYNECOLOGY
- Opsoclonus myoclonus after human papilloma virus vaccine in a pediatric patient
- (2009) James E. McCarthy et al. PARKINSONISM & RELATED DISORDERS
- Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy
- (2009) Samar Ojaimi et al. VACCINE
- Immune thrombocytopenic purpura following human papillomavirus vaccination
- (2009) Gregory Pugnet et al. VACCINE
- Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far
- (2009) Theodoros Agorastos et al. VACCINE
- Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events
- (2009) Torbjörn Callréus et al. VACCINE
- Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine
- (2009) Ali Rowhani-Rahbar et al. VACCINE
- Aluminum Granuloma After Administration of the Quadrivalent Human Papillomavirus Vaccine. Report of a Case
- (2008) Derek K Marsee et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Global epidemiology of sexually transmitted diseases
- (2008) Carlos T. Da Ros et al. ASIAN JOURNAL OF ANDROLOGY
- Anaphylaxis following quadrivalent human papillomavirus vaccination
- (2008) J. M.L. Brotherton et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years
- (2008) Tiina Petäjä et al. JOURNAL OF ADOLESCENT HEALTH
- HPV vaccine: a cornerstone of female health a possible cause of ADEM?
- (2008) V. Schäffer et al. JOURNAL OF NEUROLOGY
- CNS demyelination and quadrivalent HPV vaccination
- (2008) I Sutton et al. Multiple Sclerosis Journal
- Development of Unilateral Cervical and Supraclavicular Lymphadenopathy After Human Papilloma Virus Vaccination
- (2008) James Studdiford et al. PHARMACOTHERAPY
- Brachial plexus neuritis following HPV vaccination
- (2008) Ph. Debeer et al. VACCINE
- Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
- (2008) Thomas Verstraeten et al. VACCINE
- Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years
- (2008) Tino F. Schwarz et al. VACCINE
- Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects
- (2007) S. KANG et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines
- (2007) Cosette M. Wheeler et al. VACCINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started